266 related articles for article (PubMed ID: 23788045)
21. [The Concept of Immunogenic Cell Death in Antitumor Immunity].
Fučíková J; Bartůňková J; Špíšek R
Klin Onkol; 2015; 28 Suppl 4():4S48-55. PubMed ID: 26647889
[TBL] [Abstract][Full Text] [Related]
22. Quantification of eIF2alpha phosphorylation during immunogenic cell death.
Bezu L; Wu Chuang A; Humeau J; Kroemer G; Kepp O
Methods Enzymol; 2019; 629():53-69. PubMed ID: 31727256
[TBL] [Abstract][Full Text] [Related]
23. The 'kiss of death' by dendritic cells to cancer cells.
Chan CW; Housseau F
Cell Death Differ; 2008 Jan; 15(1):58-69. PubMed ID: 17948029
[TBL] [Abstract][Full Text] [Related]
24. A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine.
Park HJ; Jang GY; Kim YS; Park JH; Lee SE; Vo MC; Lee JJ; Han HD; Jung ID; Kang TH; Park YM
J Immunother Cancer; 2019 Feb; 7(1):60. PubMed ID: 30819254
[TBL] [Abstract][Full Text] [Related]
25. The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy.
Apetoh L; Ghiringhelli F; Tesniere A; Criollo A; Ortiz C; Lidereau R; Mariette C; Chaput N; Mira JP; Delaloge S; André F; Tursz T; Kroemer G; Zitvogel L
Immunol Rev; 2007 Dec; 220():47-59. PubMed ID: 17979839
[TBL] [Abstract][Full Text] [Related]
26. Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies.
Wang Q; Ju X; Wang J; Fan Y; Ren M; Zhang H
Cancer Lett; 2018 Dec; 438():17-23. PubMed ID: 30217563
[TBL] [Abstract][Full Text] [Related]
27. Fucoidin enhances dendritic cell-mediated T-cell cytotoxicity against NY-ESO-1 expressing human cancer cells.
Hu Y; Cheng SC; Chan KT; Ke Y; Xue B; Sin FW; Zeng C; Xie Y
Biochem Biophys Res Commun; 2010 Feb; 392(3):329-34. PubMed ID: 20067767
[TBL] [Abstract][Full Text] [Related]
28. Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer.
Fucikova J; Kasikova L; Truxova I; Laco J; Skapa P; Ryska A; Spisek R
Immunol Lett; 2018 Jan; 193():25-34. PubMed ID: 29175313
[TBL] [Abstract][Full Text] [Related]
29. Molecular characteristics of immunogenic cancer cell death.
Tesniere A; Panaretakis T; Kepp O; Apetoh L; Ghiringhelli F; Zitvogel L; Kroemer G
Cell Death Differ; 2008 Jan; 15(1):3-12. PubMed ID: 18007663
[TBL] [Abstract][Full Text] [Related]
30. CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunity.
Shirota H; Klinman DM
Cancer Immunol Immunother; 2011 May; 60(5):659-69. PubMed ID: 21318638
[TBL] [Abstract][Full Text] [Related]
31. Immunogenic tumor cell death induced by chemoradiotherapy in a clinical setting.
Kono K; Mimura K
Oncoimmunology; 2013 Jan; 2(1):e22197. PubMed ID: 23482346
[TBL] [Abstract][Full Text] [Related]
32. Stimulation of dendritic cells by DAMPs in ALA-PDT treated SCC tumor cells.
Wang X; Ji J; Zhang H; Fan Z; Zhang L; Shi L; Zhou F; Chen WR; Wang H; Wang X
Oncotarget; 2015 Dec; 6(42):44688-702. PubMed ID: 26625309
[TBL] [Abstract][Full Text] [Related]
33. Extracorporeal photochemotherapy induces bona fide immunogenic cell death.
Tatsuno K; Yamazaki T; Hanlon D; Han P; Robinson E; Sobolev O; Yurter A; Rivera-Molina F; Arshad N; Edelson RL; Galluzzi L
Cell Death Dis; 2019 Aug; 10(8):578. PubMed ID: 31371700
[TBL] [Abstract][Full Text] [Related]
34. [Antitumoral immunization during cancer chemotherapy].
Zitvogel L; Hannani D; Aymeric L; Kepp O; Martins I; Kroemer G
Bull Acad Natl Med; 2012 Jun; 196(6):1075-86. PubMed ID: 23596856
[TBL] [Abstract][Full Text] [Related]
35. In vitro PUVA treatment triggers calreticulin exposition and HMGB1 release by dying T lymphocytes in GVHD: New insights in extracorporeal photopheresis.
Coppard C; Hannani D; Humbert M; Gauthier V; Plumas J; Merlin E; Gabert F; Chaperot L
J Clin Apher; 2019 Aug; 34(4):450-460. PubMed ID: 30860623
[TBL] [Abstract][Full Text] [Related]
36. Dendritic Cells and Cancer Immunity.
Gardner A; Ruffell B
Trends Immunol; 2016 Dec; 37(12):855-865. PubMed ID: 27793569
[TBL] [Abstract][Full Text] [Related]
37. Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner.
Werthmöller N; Frey B; Wunderlich R; Fietkau R; Gaipl US
Cell Death Dis; 2015 May; 6(5):e1761. PubMed ID: 25973681
[TBL] [Abstract][Full Text] [Related]
38. High hydrostatic pressure induces immunogenic cell death in human tumor cells.
Fucikova J; Moserova I; Truxova I; Hermanova I; Vancurova I; Partlova S; Fialova A; Sojka L; Cartron PF; Houska M; Rob L; Bartunkova J; Spisek R
Int J Cancer; 2014 Sep; 135(5):1165-77. PubMed ID: 24500981
[TBL] [Abstract][Full Text] [Related]
39. Immunogenic cell death and DAMPs in cancer therapy.
Krysko DV; Garg AD; Kaczmarek A; Krysko O; Agostinis P; Vandenabeele P
Nat Rev Cancer; 2012 Dec; 12(12):860-75. PubMed ID: 23151605
[TBL] [Abstract][Full Text] [Related]
40. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
Esposito A; Criscitiello C; Curigliano G
Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
